Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe

Hdl Handle:
http://hdl.handle.net/10144/619097
Title:
Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
Authors:
Ndlovu, Z; Fajardo, E; Mbofana, E; Maparo, T; Garone, D; Metcalf, C; Bygrave, H; Kao, K; Zinyowera, S
Journal:
PLoS ONE
Abstract:
HIV Viral Load and Early Infant Diagnosis technologies in many high burden settings are restricted to centralized laboratory testing, leading to long result turnaround times and patient attrition. GeneXpert (Cepheid, CA, USA) is a polyvalent near point-of-care platform and is widely implemented for Xpert MTB/RIF diagnosis. This study sought to evaluate the operational feasibility of integrated HIV VL, EID and MTB/RIF testing in new GeneXpert platforms.
Publisher:
Public Library of Science
Issue Date:
2-Mar-2018
URI:
http://hdl.handle.net/10144/619097
DOI:
10.1371/journal.pone.0193577
PubMed ID:
29499042
Submitted date:
2018-04-17
Language:
en
ISSN:
1932-6203
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorNdlovu, Zen
dc.contributor.authorFajardo, Een
dc.contributor.authorMbofana, Een
dc.contributor.authorMaparo, Ten
dc.contributor.authorGarone, Den
dc.contributor.authorMetcalf, Cen
dc.contributor.authorBygrave, Hen
dc.contributor.authorKao, Ken
dc.contributor.authorZinyowera, Sen
dc.date.accessioned2018-04-23T12:29:00Z-
dc.date.available2018-04-23T12:29:00Z-
dc.date.issued2018-03-02-
dc.date.submitted2018-04-17-
dc.identifier.citationMultidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe. 2018, 13 (3):e0193577 PLoS ONEen
dc.identifier.issn1932-6203-
dc.identifier.pmid29499042-
dc.identifier.doi10.1371/journal.pone.0193577-
dc.identifier.urihttp://hdl.handle.net/10144/619097-
dc.description.abstractHIV Viral Load and Early Infant Diagnosis technologies in many high burden settings are restricted to centralized laboratory testing, leading to long result turnaround times and patient attrition. GeneXpert (Cepheid, CA, USA) is a polyvalent near point-of-care platform and is widely implemented for Xpert MTB/RIF diagnosis. This study sought to evaluate the operational feasibility of integrated HIV VL, EID and MTB/RIF testing in new GeneXpert platforms.en
dc.language.isoenen
dc.publisherPublic Library of Scienceen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleMultidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabween
dc.identifier.journalPLoS ONEen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.